Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are ...

Distalmotion, the global MedTech company expanding access to robotic surgery in outpatient sites of care, announced that it submitted a 510(k) application to the US Food and Drug Administration (FDA) ...

Amneal and BioCorRx have earned the ire of the FDA’s Office of Prescription Drug Promotion (OPDP), with both being hit by ...

Alleged misuse of hospital medications in Argentina has triggered an investigation oft health professionals for the suspected ...

This little-known biotech company has a different strategy than the established weight-loss drug market leaders. But is it ...

The FDA is seeking (PDF) new powers to hold companies accountable for misleading direct-to-consumer (DTC) ads, adding legislat | The FDA is seeking new powers to hold companies accountable for ...

Pediatric malignant gliomas are rare, aggressive brain tumors with limited treatment options and poor outcomes, where current standards of care—including surgery and radiation—often fail to prevent ...

Eli Lilly rises after $7.8 billion Centessa deal to expand sleep drugs. Centessa ADR jumps 45% as Lilly bets on orexin ...

Building on its established use in the United States, BD will also extend its AI-powered BD Incada™ Analytics platform to ...

Officers from the Los Banos Police Department’s gang unit arrested a 43-year-old convicted felon on gun and drug charges on ...

When a biopharma company known for its expertise in a specific domain turns to a collaborator to expand its capabilities in ...